Chorea is a movement disorder that causes involuntary, unpredictable body movements. Symptoms may include fidgeting to severe uncontrolled arm and leg movements. Chorea is a movement disorder that ...

Chorea is an involuntary movement disorder that causes irregular muscle movements. It occurs due to the overactivity of dopamine in the brain, which can have many causes. Treatment and outlook ...

Chorea in Huntington’s Disease. Huntington's disease is the best-known cause of chorea. It is a rare disease, which affects only about one in 10,000 to 20,000 people.

Chorea is one type of hyperkinetic movement disorder, or dyskinesia. Each type of dyskinesia has unique features, causes, and treatments. If you are experiencing involuntary movements and have any ...

The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo, according to a recent international study led by ...

The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo, according to a recent international study led by ...

- Statistically Significant Improvement in Chorea Associated with Huntington's Disease Seen as Early as Week 2 - Chorea Improvement Supported by Statistically Significant Clinical Global ...

The Food and Drug Administration (FDA) has approved Ingrezza ® (valbenazine) for the treatment of adults with chorea associated with Huntington disease.. Ingrezza is an inhibitor of vesicular ...

Chorea is a movement disorder caused by a hereditary condition called Huntington’s disease. Chorea can cause uncontrolled movements of the hands, feet, and face.

The effect of INGREZZA on chorea over time was assessed using mean changes from baseline in the Unified Huntington's Disease Rating Scale Total Maximal Chorea (TMC) score and response status ...

SAN DIEGO, Sept. 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT®-HD2 study of INGREZZA® (valbenazine ...